CHEBI:173104 - narlaprevir

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name narlaprevir
ChEBI ID CHEBI:173104
Definition An azabicyclohexane that is (1R,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane substituted by [(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]aminoacyl and N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl groups at positions 2S and 3, respectively. It is a hepatitis C virus (HCV) NS3/4A serine protease inhibitor (Ki = 6 nM) that is used for the treatment of chronic hepatitis C.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter R. Stephan
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C36H61N5O7S
Net Charge 0
Average Mass 707.970
Monoisotopic Mass 707.42917
InChI InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1
InChIKey RICZEKWVNZFTNZ-LFGITCQGSA-N
SMILES [H][C@]12CN([C@H](C(=O)N[C@@H](CCCC)C(=O)C(=O)NC3CC3)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C
Roles Classification
Biological Role(s): hepatitis C protease inhibitor
An inhibitor of hepatitis C protease, an enzyme required for production of proteins needed for viral assembly.
antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
An EC 3.4.22.* (cysteine endopeptidase) inhibitor that interferes with the action of SARS coronavirus main proteinase (EC 3.4.22.69).
anticoronaviral agent
Any antiviral agent which inhibits the activity of coronaviruses.
Application(s): antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing narlaprevir (CHEBI:173104) has role anticoronaviral agent (CHEBI:149553)
narlaprevir (CHEBI:173104) has role antiviral drug (CHEBI:36044)
narlaprevir (CHEBI:173104) has role EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor (CHEBI:147285)
narlaprevir (CHEBI:173104) has role hepatitis C protease inhibitor (CHEBI:64924)
narlaprevir (CHEBI:173104) is a azabicyclohexane (CHEBI:170008)
narlaprevir (CHEBI:173104) is a cyclopropanes (CHEBI:51454)
narlaprevir (CHEBI:173104) is a pyrrolidinecarboxamide (CHEBI:46770)
narlaprevir (CHEBI:173104) is a secondary carboxamide (CHEBI:140325)
narlaprevir (CHEBI:173104) is a sulfone (CHEBI:35850)
narlaprevir (CHEBI:173104) is a tertiary carboxamide (CHEBI:140326)
narlaprevir (CHEBI:173104) is a ureas (CHEBI:47857)
IUPAC Name
(1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
INNs Sources
narlaprevir WHO MedNet
narlaprevir WHO MedNet
narlaprévir WHO MedNet
narlaprevirum WHO MedNet
Synonyms Sources
(1R,2S,5S)-3-{(2S)-2-[({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)amino]-3,3-dimethylbutanoyl}-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide IUPAC
(1R,2S,5S)-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-[3-methyl-N-({1-[(2-methylpropane-2-sulfonyl)methyl]cyclohexyl}carbamoyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide IUPAC
SCH 900518 ChemIDplus
SCH-900518 ChemIDplus
SCH900518 ChemIDplus
Brand Name Source
Arlansa ChEBI
Manual Xrefs Databases
10031710 ChemSpider
D09644 KEGG DRUG
DB14760 DrugBank
LSM-45473 LINCS
Narlaprevir Wikipedia
NNA PDBeChem
View more database links
Registry Number Type Source
865466-24-6 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
20308381 PubMed citation SUBMITTER
20938912 PubMed citation Europe PMC
21473061 PubMed citation Europe PMC
21627104 PubMed citation Europe PMC
22263860 PubMed citation Europe PMC
23490393 PubMed citation Europe PMC
24168257 PubMed citation Europe PMC
24900178 PubMed citation Europe PMC
25178998 PubMed citation Europe PMC
27645244 PubMed citation SUBMITTER
32598756 PubMed citation Europe PMC
33152262 PubMed citation Europe PMC
33524017 PubMed citation Europe PMC
33538596 PubMed citation Europe PMC
33542181 PubMed citation Europe PMC
Last Modified
28 May 2021
General Comment
2021-05-28 The 3D structure shown is that of narlaprevir in its protein bound form.